The positive analyst ratings and the increased price target suggest that the market's perception of Roivant Sciences is improving. This optimism is likely to influence investor sentiment and could lead to a short-term increase in ROIV's stock price, as the market often reacts to analyst ratings and price targets. The unanimous bullish sentiment and the substantial upside implied by the target price reinforce the potential for a positive impact on the stock.